• Trials and Research

  Neurofilament Light Chain Can Predict RRMS Progression

  Posted by MS News Today Moderator on June 29, 2018 at 7:32 am

  Read about how the levels of neurofilament light chain (NfL) are a reliable biomarker of disease worsening and progression in RRMS patients, and how Gilenya treatment can reduce its levels for up to 10 years.

  Check out more about this subject here: #EAN2018 – Levels of Neurofilament Light Chain Can Predict Disease Progression in RRMS, Study Shows

  What do you think about this research?

  replied 6 years, 5 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply